Sitrap (Sitagliptin) Tablets by Life Pharmaceutical Company

Sitrap 100mg

Drug Catagory: Dipeptidyl-Peptidase IV Inhibitors, Antidiabetics

Composition:

Each Tablet contains:

  • Sitagliptin………….100mg

Pharmacological Action:

  • Sitagliptin: is an orally-active member of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. The benefit of this medicine is expected to be its lower side-effects of hypoglycemia in the control of blood glucose values. The drug works to diminish the effects of a protein/enzyme (by the inhibition of this protein/enzyme) on the pancreas at the level of release of glucagon (diminishes its release) and at the level of insulin (increases its synthesis and release) until blood glucose levels are restored toward normal, in which case the protein/enzyme-enzyme inhibitor becomes less effective and the amounts of insulin released diminishes thus diminishing the “overshoot” of hypoglycemia seen in other oral hypoglycemic agents.

Presentation:

  • Tablet

Write a Reply or Comment

Your email address will not be published.

Time limit is exhausted. Please reload the CAPTCHA.